Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients

Completed · Phase 2 · Has a placebo group

Conditions studied: Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye, Ocular Hypertension (OHT)

In brief

Qlaris' Phase 2 clinical trial investigating the safety, tolerability, and ocular hypotensive efficacy of QLS-111 in primary open-angle glaucoma (POAG) or ocular hypertension patients.

Key facts

Study ID
NCT06016972
Run by
Qlaris Bio, Inc.
People needed
63
Starts
2024-03-05
Expected to finish
2024-08-20
Last updated by the study team
2025-01-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.